Subcutaneous Infliximab – the beginning of the era of biobetters in the treatment of immune-mediated inflammatory diseases
Authors:
Michnová K.
Published in:
Gastroent Hepatol 2022; 76(3): 268-271
Category:
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
![Issue 3](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/ae63e6d2318bf328e2cae7b0af0739be.jpg)
2022 Issue 3
Most read in this issue
- Endoscopic therapy of gastroesophageal reflux disease using radiofrequency energy (Stretta procedure) – treatment of the first patients in the Czech Republic
- Gastroscopy – quality standards of the Czech Society of Gastroenterology
- Prof. Julius Špičák, MD, PhD, jubilant
- A rare cause of biliary obstruction – a case study